About FirstWord Biosimilars

FirstWord is an innovative industry intelligence leader serving nearly 200,000 Pharma and MedTech professionals worldwide.

FirstWord publishes FirstWord Pharma, the most widely used news service for the global pharmaceutical industry, along with FirstWord Pharma PLUS, the customisable news and intelligence service delivering a knowledge edge to readers, and FirstWord MedTech and FirstWord MedTech PLUS.

FirstWord delivers actionable insights and expert views through its report brands: FirstWord Dossier reports present the latest thinking on important trends and the most challenging issues facing pharma; FirstWord's Therapy Trends reports provide views from KOLs and consensus market forecasts relating to current and future therapies for the treatment of major medical conditions; FirstView informs executives with an authoritative, primary research-based analysis of innovations and developments that are reshaping the biopharma industry.

FirstWord Biosimilars brings you the latest biosimilars news.

FirstWord.  Where people who know first, go first.